Liq-NOL Efficacy in Pediatric Patients With Down Syndrome
Status:
Completed
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The purpose of this study is to measure the effects of LiQ-NOL supplementation on language
production using the Clinical Evaluation of Language Fundamentals test, language sampling
using the mean length of utterance test, and speech articulation using the Goldman-Fristoe
Test of Articulation.